Seborrheic Dermatitis And Psoriasis
Roycederm Seborrheic Dermatitis And Psoriasis Shampoo
Ehy Holdings Llc
Human Otc Drug
NDC 81799-007Seborrheic Dermatitis And Psoriasis also known as Roycederm Seborrheic Dermatitis And Psoriasis Shampoo is a human otc drug labeled by 'Ehy Holdings Llc'. National Drug Code (NDC) number for Seborrheic Dermatitis And Psoriasis is 81799-007. This drug is available in dosage form of Shampoo. The names of the active, medicinal ingredients in Seborrheic Dermatitis And Psoriasis drug includes Wormwood - 3 mg/100mL . The currest status of Seborrheic Dermatitis And Psoriasis drug is Active.
Drug Information:
| Drug NDC: | 81799-007 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Seborrheic Dermatitis And Psoriasis |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Roycederm Seborrheic Dermatitis And Psoriasis Shampoo |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Ehy Holdings Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Shampoo |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | WORMWOOD - 3 mg/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 11 Jan, 2023 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Ehy Holdings LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0810110570900
|
| UPC stands for Universal Product Code. |
| UNII: | F84709P2XV
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 81799-007-01 | 250 mL in 1 BOTTLE (81799-007-01) | 11 Jan, 2023 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose seborrheic
Product Elements:
Seborrheic dermatitis and psoriasis roycederm seborrheic dermatitis and psoriasis shampoo dictamnus dasycarpus root water smilax glabra whole wormwood wormwood cnidium monnieri fruit bassia scoparia pollen sophora flavescens root
Indications and Usage:
Use relieves and helps preventrecurrence of scalp: itching, flakingscaling, redness, and irritationassociated with psoriasis andseborrheic dermatitis.
Warnings:
Warnings for external use only
Do Not Use:
Warnings for external use only
When Using:
When using this productavoid contact with eyes.
Dosage and Administration:
Directions adult and children over 12 vears or old. wash handsbefore and after applying the cream. apply to affected area at the firstsign of blisters, sores, or tingling sensation. rub in gently andthoroughly. do not use more than 3 times daily. children under 12years: ask a doctor
Stop Use:
Condition worsens or does notimprove after regular use asdirected
Package Label Principal Display Panel:
Package label - principal display panel 81799-007-1 1 81799-007-1 2 81799-007-1 3 81799-006-1 1 81799-006-1 2 81799-006-1 3
Further Questions:
Visit www.roycederm.com